USV Launches Roseday CV at a Patient-Centric Price for Indian Cardiac Patients
The recent AHA/ACC 2023 Guidelines for Chronic Coronary Disease recommend considering medication costs to prevent cost-related non-adherence. Addressing this issue, USV Pvt. Ltd, a leading drug manufacturer in the diabetes and cardiology segments, has launched Roseday CV, which contains Rosuvastatin and Clopidogrel and is available in two SKUs: Roseday CV 10 at just 8.3 rupees per capsule,...
The recent AHA/ACC 2023 Guidelines for Chronic Coronary Disease recommend considering medication costs to prevent cost-related non-adherence.
Addressing this issue, USV Pvt. Ltd, a leading drug manufacturer in the diabetes and cardiology segments, has launched Roseday CV, which contains Rosuvastatin and Clopidogrel and is available in two SKUs: Roseday CV 10 at just 8.3 rupees per capsule, and Roseday CV 20 at 8.74 rupees per capsule.
It is widely available across India.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd